The increasing demand for controlled immunological study and therapeutic development has spurred significant Recombinant Human KGF2 advances in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using multiple expression systems, including microbial hosts, higher cell l